SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

NASDAQ:SIGA

SIGA Technologies, Inc.

Last Close

7.63

08/11 21:00

Market Cap

606.67M

Beta: 0.83

Volume Today

733.31K

Avg: 773.49K

PE Ratio

−64.63

PFCF: 42.17

Dividend Yield

9.90%

Payout:−0.08%

locale

market

industry

website

ipo date

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics